// App-Quantinova.ai

e21207 : Residual of circulating tumor DNA (ctDNA) indicated therapeutic efficacy of sintilimab plus docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC).

Researchers

Presenter

  • Zhehai Wang

Principal Investigators

  • Xiao Han

  • Jun Guo

  • Ming Jia

  • Changbin Zhu

  • Dongyuan Zhu

  • Xiqin Zhang

  • Xiaoyong Tang

  • Xiangjiao Meng

Medical Centers

  • Shandong Cancer Hospital, Jinan, China

  • Amoy Diagnostics, Xiamen, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Circulating DNA

Drug/Treatment

  • Sintilimab

  • Docetaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved